Longevity of sprint fidelis implantable cardioverter-defibrillator leads and risk factors for failure: Implications for patient management

Circulation

Volumn 123, Issue 4, 2011, Pages 358-363

  Hauser, Robert G ^a   Maisel, William H ^c   Friedman, Paul A ^b   Kallinen, Linda M ^a   Mugglin, Andrew S ^d   Kumar, Kapil ^c   Hodge, David O ^b   Morrison, Thomas B ^b   Hayes, David L ^b  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b MAYO CLINIC   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

cardiomyopathy hypertrophic; channelopathies; implantable cardioverter defibrillators

Indexed keywords

ADULT; AGE; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; GENDER; HEART BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; RISK ASSESSMENT; SUDDEN DEATH;

ADULT; AGED; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 79751531987     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.975219     Document Type: Article

References (23)

1. Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT. Early failure of a small-diameter high-voltage implantable cardioverterdefibrillator lead. Heart Rhythm. 2007;4:892-896. (Pubitemid 46959208)
2. Urgent Medical Device Information: Sprint Fidelis Lead Patient Management Recommendations. Minneapolis, MN: Medtronic Inc; October 15, 2007.
3. Farwell D, Green MS, Lemery R, Gollub MH, Birnie DH. Accelerating risk of Fidelis lead fracture. Heart Rhythm. 2008;5:1375-1379.
4. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm. 2009;6:605-610.
5. Faulknier BA, Traub DM, Aktas Mk, Aguila A, Rosero S, Daubert JP, Hall B, Shah A, Taylor S, McNitt S, Moss AJ, Zareba W, Huang DT. Time-dependent risk of Fidelis lead failure. Am J Cardiol. 2010;105: 95-99.
6. Morrison TB, Rea RF, Hodge DO, Crusan D, Koestler C, Asirvatham SJ, Bradley D, Shen WK, Munger TM, Hammill SC, Friedman PA. Risk factors for implantable defibrillator lead fracture in a recalled and nonrecalled lead. J Cardiovasc Electrophysiol. 2010;21:671-677.
7. Sprint Fidelis model 6949 lead performance. Available at: http:// www.medtronic.com/product-advisories/physician/sprint-fidelis/6949. Accessed May 29, 2010.
8. Schoenfeld MH, Compton SJ, Mead RH, Weiss DN, Sherfesee L, Englund J, Mongeon LR. Remote monitoring of implantable cardioverterdefibrillators: a prospective analysis. Pacing Clin Electrophysiol. 2004; 27:757-763. (Pubitemid 38758757)
9. Maisel WH, Hauser RG, Hammill SC, Ellenbogen KA, Epstein AE, Hayes DL, Alpert JS, Berger RD, Curtis AM, Dubin AM, Estes MNA, Gura MT, Krahn AD, Lampert R, Lindsay BD, Wilcoff BL. Recommen- dations from the Heart Rhythm Society Task Force on lead performance policies and guidelines. Heart Rhythm. 2009;6:869-885.
10. Dorey FJ, Korn EL. Effective sample size of confidence intervals for survival probabilities. Stat Med. 1987;6:679-687.
11. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
12. Harrell FE Jr. Cox proportional hazards regression model. Regression Modeling: With Application to Linear Models, Logistic Regression, and Survival Analysis. New York, NY: Springer Verlag; 2001:493.
13. Lehmann EL, Romano JP. Unbiasedness: theory and first applications. Testing Statistical Hypotheses. 3rd ed. New York, NY: Springer; 2005:125.
14. Hauser RG, Maron BJ, Marine JE, Lampert R, Kadish AH, Winters SL, Scher DL, Biria M, Kalia A. Safety and efficacy of transvenous highvoltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients. Heart Rhythm. 2008;5:1517-1522.
15. Kleeman T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of-10 years. Circulation. 2007;115:2472-2480.
16. Sarkozy A, Boussy T, Kourgiannides G, Chierchia G-B, Richter S, De Potter T, Geelen P, Wellens F, Spreeuwenberg MD, Brugada P. Long-term follow-up of primary prophylactic implantable cardioverterdefibrillator therapy in Brugada syndrome. Eur Heart J. 2007;28: 334-344.
17. Monnig G, Kobe J, Loher A, Eckardt L, Wedekind H, Scheld HH, Haverkamp W, Milberg P, Breithardt G. Implantable cardioverterdefibrillator therapy in patients with congenital long-QT syndrome: a long-term follow-up. Heart Rhythm. 2005;2:497-504. (Pubitemid 40521363)
18. Ha ACT, Vezi BZ, Keren A, Alanazi H, Gollob MH, Green MS. Predictors of fracture risk of a small caliber implantable cardioverter defibrillator lead. Pacing Clin Electrophysiol. 2010;33:437-443.
19. Lee DS, Krahn AD, Healey JS, Birnie D, Crystal E, Dorian P, Simpson CS, Khaykin Y, Cameron D, Janmohamed A, Yee R, Austin PC, Chen Z, Hardy J, Tu JV. Evaluation of early complications related to De novo cardioverter defibrillator implantation. J Am Coll Cardiol. 2010;55: 774-782.
20. Baxter W, Skadsberg N, Johnson B, Crossley G, Foreman B. New unanticipated insights on peak lead bending during pectoralis flexure [abstract]. Heart Rhythm. 2010;7:S309.
21. Beukema RJ, Misler ARR, Delnoy PPHM, Elvan SA. Characteristics of Sprint Fidelis lead failure. Neth Heart J. 2010;18:12-17.
22. Johansen JB, Amsbo P, Mortensen PT, Jorgensen OD, Videbaek R, Heath FP, Haarbo J, Moller M. Performance of the Medtronic Sprint Fidelis ICD lead (6930-31 and 6948-49) in 901 consecutive Danish patients. Heart Rhythm. 2010;7:S20. Abstract.
23. Sprint Quattro Secure model 6947 performance. Available at: http://www. medtronic.com/crm/performance/leads/defib/6947-sprint-quattro.html. Accessed May 29, 2010.